Gary Patou Xenon Pharmaceuticals Inc. (XENE) insider trading activity
Gary Patou is of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 23,573 shares of XENE, which is worth approximately $905,674. The most recent transaction as insider was on Nov 22, 2024, when has been sold 1,695 shares (Common Shares) at a price of $39.8 per share, resulting in proceeds of $67,461. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
23.6K
0%
3M change
0%
12M change
Total Value Held
$905,674
GARY PATOU Transaction History
GP
Gary Patou
Burnaby, A1